These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18502950)

  • 61. Do quality-adjusted life years take account of lost income? Evidence from an Australian survey.
    Richardson J; Peacock SJ; Iezzi A
    Eur J Health Econ; 2009 Feb; 10(1):103-9. PubMed ID: 18458973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In the land of blind decision making, is one-eyed economics the king?
    Drummond M; Donaldson C
    Appl Health Econ Health Policy; 2003; 2(2):73-6. PubMed ID: 14619276
    [No Abstract]   [Full Text] [Related]  

  • 63. Evaluating interventions in health: a reconciliatory approach.
    Wolff J; Edwards S; Richmond S; Orr S; Rees G
    Bioethics; 2012 Nov; 26(9):455-63. PubMed ID: 21535065
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of comorbidities on treatment decisions.
    Bleichrodt H; Crainich D; Eeckhoudt L
    J Health Econ; 2003 Sep; 22(5):805-20. PubMed ID: 12946460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A clinician's guide to utility measurement.
    Redelmeier DA; Detsky AS
    Prim Care; 1995 Jun; 22(2):271-80. PubMed ID: 7617786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The health effects of education: a meta-analysis.
    Furnée CA; Groot W; van den Brink HM
    Eur J Public Health; 2008 Aug; 18(4):417-21. PubMed ID: 18434381
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Economics and public health: an arranged marriage.
    Barendregt JJ
    Eur J Public Health; 2007 Apr; 17(2):124. PubMed ID: 17068005
    [No Abstract]   [Full Text] [Related]  

  • 68. Measuring the quality of life.
    Treasure T; Holmes L
    J Heart Valve Dis; 1995 Jul; 4(4):337-8. PubMed ID: 7582137
    [No Abstract]   [Full Text] [Related]  

  • 69. [Quality of life evaluation: public health aspects].
    Schwarzinger M; Bastuji-Garin S; Durand-Zaleski I
    Ann Dermatol Venereol; 1999 Feb; 126(2):168-75. PubMed ID: 10352837
    [No Abstract]   [Full Text] [Related]  

  • 70. Comments on the Prosser et Al approach to value disease reduction in children.
    Beutels P; Viney RC
    Pediatrics; 2004 Nov; 114(5):1375; author reply 1375-6. PubMed ID: 15520142
    [No Abstract]   [Full Text] [Related]  

  • 71. Qualia years (qy) [corrected]--not years--should be the unit of measurement of QALYs, DALYs, life expectancy, and life.
    Dimoliatis ID
    J Epidemiol Community Health; 2004 Dec; 58(12):1054-5. PubMed ID: 15547073
    [No Abstract]   [Full Text] [Related]  

  • 72. [Health services need knowledge of how the public values health].
    Persson U; Hjelmgren J
    Lakartidningen; 2003 Oct; 100(43):3436-7. PubMed ID: 14626774
    [No Abstract]   [Full Text] [Related]  

  • 73. 'Is there a case for using visual analogue scale valuations in CUA' by Parkin and Devlin. A response: 'yes there is a case, but what does it add to ordinal data?'.
    Brazier J; McCabe C
    Health Econ; 2007 Jun; 16(6):645-7; discussion 649-51. PubMed ID: 17535007
    [No Abstract]   [Full Text] [Related]  

  • 74. Retaining, and enhancing, the QALY.
    Lipscomb J; Drummond M; Fryback D; Gold M; Revicki D
    Value Health; 2009 Mar; 12 Suppl 1():S18-26. PubMed ID: 19250127
    [No Abstract]   [Full Text] [Related]  

  • 75. Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement.
    Attema AE; Brouwer WB
    Health Econ; 2008 Jul; 17(7):877-85. PubMed ID: 18074409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Use of the quality of life concept in medical research--useful or useless?].
    Wyller TB
    Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4247-51. PubMed ID: 9857811
    [No Abstract]   [Full Text] [Related]  

  • 77. How much are Americans willing to pay for a quality-adjusted life year?
    Weinstein MC
    Med Care; 2008 Apr; 46(4):343-5. PubMed ID: 18362811
    [No Abstract]   [Full Text] [Related]  

  • 78. [Analysis of disease burden of diabetes mellitus in 1971-2000 in Shanghai].
    Zhang ZJ; Li SB; Zhao GM; Han M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):338. PubMed ID: 15498252
    [No Abstract]   [Full Text] [Related]  

  • 79. Toward quality assurance in QALY calculations.
    Nord E
    Int J Technol Assess Health Care; 1993; 9(1):37-45. PubMed ID: 8423115
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [What is a cost-benefit analysis?].
    Müller-Bohn T
    Med Monatsschr Pharm; 2004 Oct; 27(10):328-30. PubMed ID: 15527174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.